C12Y 304/21079
Granzyme b
Official title: Granzyme B (3.4.21.79)
C12Y304/21079 (Granzyme b) appears on 13 US grants and 37 published applications in this corpus.
Search patents in C12Y- Granted patents
- 13
- Published applications
- 37
- Assignees
- 31
- Inventors
- 106
- Latest grant
- 10 Mar 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2006 | 0 | 1 |
| 2007 | 0 | 1 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 1 |
| 2015 | 1 | 3 |
| 2016 | 1 | 1 |
| 2017 | 2 | 6 |
| 2018 | 1 | 0 |
| 2019 | 1 | 4 |
| 2020 | 1 | 2 |
| 2021 | 1 | 2 |
| 2022 | 1 | 2 |
| 2023 | 1 | 1 |
| 2024 | 2 | 4 |
| 2025 | 0 | 5 |
| 2026 | 1 | 4 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Cytotoxic molecules responsive to intracellular ligands for selective T cell mediated killing10 Mar 2026US 12,570,968 B2The Regents of the University of California
- Hsp70 based combination therapy6 Aug 2024US 12,053,505 B2Multimmune GmbH
- Cell-targeted cytotoxic constructs27 Feb 2024US 11,913,043 B2Research Development Foundation
- Drug delivery means29 Aug 2023US 11,737,976 B2Therasyn Sensors, Inc.
- Cytotoxic molecules responsive to intracellular ligands for selective T cell mediated killing12 Jul 2022US 11,384,350 B2The Regents of the University of California
- Engineered natural killer cells with enhanced antitumor memory responses3 Sep 2026US 2026/0258360 A1Board of Regents, The University of Texas System
- Granzyme expressing t cells and methods of use27 Aug 2026US 2026/0248851 A1The Regents of the University of Colorado, a body corporate
- Pharmaceutical compositions comprising protein complexes13 Aug 2026US 2026/0232818 A1Onchilles Pharma, Inc.
- Method of inhibiting degrading protease activity in the skin6 Aug 2026US 2026/0224675 A1The Regents of the University of California
- Systems and Methods Incorporating Modified T-Cells27 Feb 2025US 2025/0066729 A1
Most cited
By later US patents
- Compositions and methods for treating amyotrophic lateral sclerosis14US 9,539,307 B2Research Institute At Nationwide Children's Hospital · 2017
- Drug delivery means8US 9,119,782 B22015
- Drug delivery means4US 10,092,516 B2Therasyn Sensors, Inc. · 2018
- Anti-parasitic complexes1US 10,344,082 B2Fraunhofer-Gesellschaft zur Foerderung der angewandten Forschung e. V. · 2019
- Cell-targeted cytotoxic constructs1US 11,193,117 B2Research Development Foundation · 2021